FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100453921> ?p ?o ?g. }

• W2100453921 endingPage "5733" @default.
• W2100453921 startingPage "5722" @default.
• W2100453921 abstract "Abstract Purpose: Preclinical murine model systems used for the assessment of therapeutics have not been predictive of human clinical responses, primarily because their clonotypic nature does not recapitulate the heterogeneous biology and immunosuppressive mechanisms of humans. Relevant model systems with mice that are immunologically competent are needed to evaluate the efficacy of therapeutic agents, especially immunotherapeutics. Experimental Design: Using the RCAS/Ntv-a system, mice were engineered to coexpress platelet-derived growth factor B (PDGF-B) receptor + B-cell lymphoma 2 (Bcl-2) under the control of the glioneuronal specific Nestin promoter. The degree and type of tumor-mediated immunosuppression were determined in these endogenously arising gliomas on the basis of the presence of macrophages and regulatory T cells. The immunotherapeutic agent WP1066 was tested in vivo to assess therapeutic efficacy and immunomodulation. Results: Ntv-a mice were injected with RCAS vectors to express PDGF-B + Bcl-2, resulting in both low- and high-grade gliomas. Consistent with observations in human high-grade gliomas, mice with high-grade gliomas also developed a marked intratumoral influx of macrophages that was influenced by tumor signal transducer and activator of transduction 3 (STAT3) expression. The presence of intratumoral F4/80 macrophages was a negative prognosticator for long-term survival. In mice coexpressing PDGF-B + Bcl-2that were treated with WP1066, there was 55.5% increase in median survival time (P &lt; 0.01), with an associated inhibition of intratumoral STAT3 and macrophages. Conclusions: Although randomization is necessary for including mice in a therapeutic trial, these murine model systems are more suitable for testing therapeutics, especially immunotherapeutics, in the context of translational studies. Clin Cancer Res; 16(23); 5722–33. ©2010 AACR." @default.
• W2100453921 created "2016-06-24" @default.
• W2100453921 creator A5012403937 @default.
• W2100453921 creator A5017578103 @default.
• W2100453921 creator A5062037505 @default.
• W2100453921 creator A5062959791 @default.
• W2100453921 creator A5066544434 @default.
• W2100453921 creator A5067193458 @default.
• W2100453921 creator A5079081497 @default.
• W2100453921 creator A5086792863 @default.
• W2100453921 creator A5088821817 @default.
• W2100453921 creator A5091806633 @default.
• W2100453921 date "2010-12-01" @default.
• W2100453921 modified "2023-10-10" @default.
• W2100453921 title "Intratumoral Mediated Immunosuppression is Prognostic in Genetically Engineered Murine Models of Glioma and Correlates to Immunotherapeutic Responses" @default.
• W2100453921 cites W1480357432 @default.
• W2100453921 cites W1965462445 @default.
• W2100453921 cites W1973249762 @default.
• W2100453921 cites W1974640999 @default.
• W2100453921 cites W1975398973 @default.
• W2100453921 cites W1977979649 @default.
• W2100453921 cites W1978956991 @default.
• W2100453921 cites W1980500001 @default.
• W2100453921 cites W1983077588 @default.
• W2100453921 cites W1987388371 @default.
• W2100453921 cites W1998592999 @default.
• W2100453921 cites W2001679453 @default.
• W2100453921 cites W2006379003 @default.
• W2100453921 cites W2010677999 @default.
• W2100453921 cites W2012084975 @default.
• W2100453921 cites W2018233112 @default.
• W2100453921 cites W2027382240 @default.
• W2100453921 cites W2035716151 @default.
• W2100453921 cites W2040773741 @default.
• W2100453921 cites W2041578282 @default.
• W2100453921 cites W2042794591 @default.
• W2100453921 cites W2062165914 @default.
• W2100453921 cites W2066562900 @default.
• W2100453921 cites W2069415454 @default.
• W2100453921 cites W2082354253 @default.
• W2100453921 cites W2089457438 @default.
• W2100453921 cites W2097109659 @default.
• W2100453921 cites W2097672049 @default.
• W2100453921 cites W2104917184 @default.
• W2100453921 cites W2106537986 @default.
• W2100453921 cites W2107743003 @default.
• W2100453921 cites W2109610561 @default.
• W2100453921 cites W2114027214 @default.
• W2100453921 cites W2114850139 @default.
• W2100453921 cites W2119482835 @default.
• W2100453921 cites W2125493895 @default.
• W2100453921 cites W2125521995 @default.
• W2100453921 cites W2138419309 @default.
• W2100453921 cites W2141900493 @default.
• W2100453921 cites W2143082339 @default.
• W2100453921 cites W2148131374 @default.
• W2100453921 cites W2149142217 @default.
• W2100453921 cites W2151513527 @default.
• W2100453921 cites W2154690224 @default.
• W2100453921 cites W2160102037 @default.
• W2100453921 cites W2165027097 @default.
• W2100453921 cites W2167600490 @default.
• W2100453921 cites W2168478794 @default.
• W2100453921 cites W2169769300 @default.
• W2100453921 cites W2169820627 @default.
• W2100453921 cites W2170957438 @default.
• W2100453921 cites W2312853461 @default.
• W2100453921 cites W2783142245 @default.
• W2100453921 cites W4293241248 @default.
• W2100453921 doi "https://doi.org/10.1158/1078-0432.ccr-10-1693" @default.
• W2100453921 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2999668" @default.
• W2100453921 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20921210" @default.
• W2100453921 hasPublicationYear "2010" @default.
• W2100453921 type Work @default.
• W2100453921 sameAs 2100453921 @default.
• W2100453921 citedByCount "68" @default.
• W2100453921 countsByYear W21004539212012 @default.
• W2100453921 countsByYear W21004539212013 @default.
• W2100453921 countsByYear W21004539212014 @default.
• W2100453921 countsByYear W21004539212015 @default.
• W2100453921 countsByYear W21004539212016 @default.
• W2100453921 countsByYear W21004539212017 @default.
• W2100453921 countsByYear W21004539212018 @default.
• W2100453921 countsByYear W21004539212019 @default.
• W2100453921 countsByYear W21004539212020 @default.
• W2100453921 countsByYear W21004539212021 @default.
• W2100453921 countsByYear W21004539212022 @default.
• W2100453921 countsByYear W21004539212023 @default.
• W2100453921 crossrefType "journal-article" @default.
• W2100453921 hasAuthorship W2100453921A5012403937 @default.
• W2100453921 hasAuthorship W2100453921A5017578103 @default.
• W2100453921 hasAuthorship W2100453921A5062037505 @default.
• W2100453921 hasAuthorship W2100453921A5062959791 @default.
• W2100453921 hasAuthorship W2100453921A5066544434 @default.
• W2100453921 hasAuthorship W2100453921A5067193458 @default.
• W2100453921 hasAuthorship W2100453921A5079081497 @default.
• W2100453921 hasAuthorship W2100453921A5086792863 @default.
• W2100453921 hasAuthorship W2100453921A5088821817 @default.

• next